
Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.
Michael Trisler, PharmD, MPH, BCIDP, is an infectious diseases clinical pharmacist at the University of Pittsburgh Medical Center Shadyside Hospital in Pennsylvania and coleads their antimicrobial stewardship program.

Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.